Catalyst Wire Dossier Catalyst Wire Dossier

Glucose-insulin-potassium (GIK) solution

glucose-insulin-potassium
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glucose-insulin-potassium (GIK) solution, covering 2015-10-30 to 2015-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Reappraisal of GIK in Acute STEMI by Pre-hospital Administration [Phase 3]

See pricing